Decentralized Clinical Trials: Global Markets

Report Code: BIO275A

Publish Date: Feb 2026

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.

Report Includes

  • An overview of the global markets for decentralized clinical trials (DCT)
  • An analysis of the global market trends with market revenue data from 2022- 2025, and projected CAGRs through 2030
  • Estimates of the size and revenue prospects of the global market, along with a market share analysis by study design, therapeutic application, deployment mode, end user, and region
  • Facts and figures pertaining to the market dynamics, technical advances, regulations, impact of macroeconomic factors, and R&D activities
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Company profiles

Report Scope

This report analyzes the trends in the global market for decentralized clinical trials. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period of 2025 through 2030. The market is segmented by study design (interventional trials, observational trials and expanded access), by therapeutic application (oncology, cardiology and other areas) and by deployment mode (cloud-based decentralized clinical trial (DCT) platforms and on-premises solutions). End users include pharmaceutical and biotechnology companies, contract research organizations (CROs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies. It offers company profiles covering financials, product portfolios and recent developments.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $8.8 Billion
Market size forecast $18.8 Billion
Growth rate CAGR of 13.7% for the forecast period of 2025-2030
Units considered $ Millions
Segments covered Study Design, Therapeutic Application, Deployment Mode, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Key Market Drivers
  • Demand for improved patient access and trial diversity.
  • Favorable regulatory support for decentralized clinical trials.
  • Technological proliferation and digital infrastructure.
  • Integration of artificial intelligence and wearable technologies.
  • Extending clinical research reach to underserved and remote areas.
Companies studied
CLARIOFORTREA
ICON PLCLABCORP
MEDABLE INC.MEDIDATA
OBVIO HEALTH USA INC.PAREXEL INTERNATIONAL (MA) CORP.
THERMO FISHER SCIENTIFIC INC.VEEVA SYSTEMS INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The estimated market size for the decentralized clinical trials market is $8.8 million by the end of 2030. The CAGR is 13.7%.
  • Demand for Improved Patient Access and Trial Diversity
  • Favorable Regulatory Outlook of Key Regulatory Agencies Set to Drive the Decentralized Clinical Trials Market
  • Technological Proliferation and Digital Infrastructure
Key challenges include-
  • Data Integrity and Security Concerns
  • Operational and Logistical Complexities
Key opportunities include-
  • Integration of Artificial Intelligence and Wearable Technologies
  • Extending Clinical Research Reach to Underserved and Remote Areas
The market is segmented by study design, therapeutic application, deployment mode, end-user, and region.
The interventional trials segment will continue to dominate at the end of 2030, representing the largest and most commercially significant product category in the global decentralized clinical trials market. These solutions account for the highest share due to increased confidence among Sponsors in implementing decentralized and/or hybrid models for Phase II-IV, which aims to enhance recruitment, retention, and operational effectiveness.
North America has the highest market share, driven by a highly advanced clinical trial ecosystem, the early adoption of digital health technologies, and favorable regulatory guidance.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Decentralized Clinical Trials: Global Markets84Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview6Free
Chapter- 3: Market Dynamics4Free
Chapter- 4: Regulatory Landscape3Free
Chapter- 5: Emerging Technologies and Developments2Free
Chapter- 6: Market Segmentation Analysis26Free
Chapter- 7: Competitive Intelligence6Free
Chapter- 8: Appendix32Free

Related Reports

Global Artificial Intelligence (AI) in Clinical Trials Market

Published - Oct 2025 | Publisher - BCC Publishing | Code - PHM285A

The global market for Artificial Intelligence (AI) in Clinical Trials was valued at $2 billion in 2024 and is estimated to increase from $2.4 billion in 2025 to reach $6.5 billion by 2030, at a compound annual growth rate (CAGR) of 22.6% from 2025 through 2030.

Global Clinical Trial Management Systems Market

Published - Jan 2022 | Publisher - BCC Publishing | Code - HLC275A

The global market for clinical trial management systems should reach $1.6 billion by 2026 from $920.8 million in 2021 at a compound annual growth rate (CAGR) of 12.2% for the forecast period of 2021 to 2026.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 73

  • Summary Table: Global Market for Decentralized Clinical Trials, by Region, Through 2030
  • Table 1: Global Market for Decentralized Clinical Trials, by Study Design, Through 2030
  • Table 2: Global Market for Interventional Decentralized Clinical Trials, by Region, Through 2030
  • Table 3: Global Market for Observational Decentralized Clinical Trials, by Region, Through 2030
  • Table 4: Global Market for Expanded Access Decentralized Clinical Trials, by Region, Through 2030
  • Table 5: Global Market for Decentralized Clinical Trials, by Therapeutic Application, Through 2030
  • Table 6: Global Market for Oncology in Decentralized Clinical Trials, by Region, Through 2030
  • Table 7: Global Market for Cardiology in Decentralized Clinical Trials, by Region, Through 2030
  • Table 8: Global Market for Other Therapeutic Applications in Decentralized Clinical Trials, by Region, Through 2030
  • Table 9: Global Market for Decentralized Clinical Trials, by Deployment Mode, Through 2030
  • Table 10: Global Market for Cloud-Based DCT Platforms in Decentralized Clinical Trials, by Region, Through 2030
Sample Report

Recent Reports

Agricultural Biotechnology: Emerging Technologies and Global Markets

Published - Sep 2026 | Publisher - BCC Publishing | Code - BIO100F

The global agricultural biotechnology market was valued at an estimated $84.7 billion in 2025 and is estimated to increase from $91.5 billion in 2026 to reach $137 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2031.

Global Organoids and Spheroids Market

Published - Sep 2026 | Publisher - BCC Publishing | Code - BIO280A

The report examines the global organoids and spheroids market, covering key trends, challenges, and market developments. It provides market estimates through 2031 and analyzes the market by product type, application, end user, and region. The study also looks at the use of organoids and spheroids in drug discovery, personalized medicine, disease studies, toxicity testing, developmental biology, and regenerative medicine. It covers major end users, including pharmaceutical and biotechnology companies, research institutes, CROs, hospitals, and diagnostic centers, along with the competitive landscape, market shares, and rankings of key businesses.

Gene Synthesis: Technologies and Global Markets

Published - Sep 2026 | Publisher - BCC Publishing | Code - BIO251B

The global market for gene synthesis was valued at $3 billion in 2025 and is estimated to increase from $3.4 billion in 2026 to reach $7.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 16.1% from 2026 to 2031.

Global Peripheral Blood Mononuclear Cells (PBMCs) Market

Published - Sep 2026 | Publisher - BCC Publishing | Code - BIO279A

The global market for peripheral blood mononuclear cells (PBMCs) was valued at $322.2 million in 2025 and, is estimated to reach $353.9 million by 2026 and $577.2 million by 2031, at a compound annual growth rate (CAGR) of 10.3% from 2026 through 2031.

Global Gene Transfer Technologies Market

Published - Sep 2026 | Publisher - BCC Publishing | Code - BIO278A

This report provides an overview of the global gene transfer technologies market, analyzing key market trends, growth drivers, challenges, and emerging technologies. The market is segmented by vector type, application, and region, with coverage across North America, Europe, Asia-Pacific, and the Rest of the World. The study also evaluates the impact of PESTEL factors, while offering strategic insights into the competitive landscape and profiles of leading companies. Market forecasts are provided through 2031.

Top Trending Reports

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Global Markets for Fermentation Ingredients

Published - Aug 2026 | Publisher - BCC Publishing | Code - FOD020H

The global market for fermentation ingredients is expected to grow from $39.8 billion in 2026 and is projected to reach $53.4 billion by the end of 2031, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2026 to 2031.

Outpatient Surgical Procedures: Global Markets

Published - Aug 2026 | Publisher - BCC Publishing | Code - MDS016B

The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.

Global Enterprise Artificial Intelligence (AI) Market

Published - Aug 2026 | Publisher - BCC Publishing | Code - IFT286B

This study examines the global enterprise AI market across key segments such as component, software deployment, technology, organization size, end user and geography. It focuses on commercially deployed AI software, services and hardware generating revenue across industries, including new deployments and the expansion of existing AI infrastructure. The analysis also covers emerging technologies, major market trends and challenges, the competitive landscape and profiles of leading companies. Regional market trends are assessed using 2025 as the base year, with forecasts from 2026 through 2031.

Molecular Diagnostics: Technologies and Global Markets

Published - Sep 2025 | Publisher - BCC Publishing | Code - BIO063F

The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Decentralized Clinical Trials: Global Markets
Sample Report
AI Sentiment